Jefferies Group LLC Merck & Co., Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	SELL	$83.49 - $94.64 $23.1 Million - $26.2 Million	-276,400 Reduced 95.67%	12,500 $1.14 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $23.1 Million - $26.2 Million	-276,400 Reduced 95.67%	12,500 $1.14 Million
Q1 2022 Sep 21, 2023	BUY	$73.51 - $82.4 $2.86 Million - $3.21 Million	38,900 Added 15.56%	288,900 $23.7 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $2.86 Million - $3.21 Million	38,900 Added 15.56%	288,900 $23.7 Million
Q4 2021 Sep 21, 2023	SELL	$72.28 - $90.54 $3.67 Million - $4.6 Million	-50,800 Reduced 16.89%	250,000 $19.2 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $3.67 Million - $4.6 Million	-50,800 Reduced 16.89%	250,000 $19.2 Million
Q3 2021 Sep 21, 2023	BUY	$71.68 - $78.83 $11.6 Million - $12.7 Million	161,600 Added 116.09%	300,800 $22.6 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $11.6 Million - $12.7 Million	161,600 Added 116.09%	300,800 $22.6 Million
Q2 2021 Sep 21, 2023	BUY	$70.31 - $77.77 $4.61 Million - $5.1 Million	65,600 Added 89.13%	139,200 $10.8 Million
Q2 2021 Aug 20, 2021	SELL	$70.31 - $77.77 $969 Million - $1.07 Billion	-13,780,800 Reduced 99.0%	139,200 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $974 Million - $1.08 Billion	13,846,400 Added 18813.04%	13,920,000 $10.8 Million
Q1 2021 Sep 21, 2023	BUY	$68.86 - $81.11 $5.07 Million - $5.97 Million	73,600 New	73,600 $5.41 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $2.83 Million - $3.33 Million	41,100 Added 126.46%	73,600 $5.67 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $914,750 - $1.04 Million	12,500 Added 62.5%	32,500 $2.7 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $5.08 Million - $5.78 Million	-72,100 Reduced 78.28%	20,000 $1.55 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $868,032 - $1.2 Million	-13,700 Reduced 12.95%	92,100 $7.09 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $5.38 Million - $6.07 Million	-69,300 Reduced 39.58%	105,800 $9.62 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $1.8 Million - $1.97 Million	23,700 Added 15.65%	175,100 $14.7 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $607,608 - $709,833	8,700 Added 6.1%	151,400 $12.7 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $389,648 - $444,416	5,600 Added 4.08%	142,700 $11.9 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $12.7 Million - $14.7 Million	-194,600 Reduced 58.67%	137,100 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $11.9 Million - $13.9 Million	205,600 Added 163.05%	331,700 $23.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $15.8 Million - $18.5 Million	-310,200 Reduced 71.1%	126,100 $7.65 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $17.6 Million - $20.4 Million	-344,500 Reduced 44.12%	436,300 $23.8 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $8.97 Million - $10.7 Million	173,700 Added 28.61%	780,800 $43.9 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $35.6 Million - $38.3 Million	607,100	607,100 $38.9 Million

Others Institutions Holding MRK

# of Institutions

3,970

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

Vanguard Group Inc Valley Forge, PA

251M
Shares

$23.8 Billion
0.45% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$19.6 Billion
0.59% of portfolio
State Street Corp Boston, MA

121M
Shares

$11.5 Billion
0.49% of portfolio
Wellington Management Group LLP Boston, MA

80.7M
Shares

$7.65 Billion
1.51% of portfolio
Geode Capital Management, LLC Boston, MA

61.2M
Shares

$5.8 Billion
0.48% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $240B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account